AKBA vs GIS · rev $102.7M vs P/E 8.2, rev $18.42B
Akebia Ther (AKBA) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
AKBA currently screens at market cap $260.1M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the AKBA and GIS stock pages for the full models.
Not investment advice.